SBRA

+ Watchlist + Portfolio

Sabra Health Care REIT, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $20.54
52-Week Range: $17.17 – $22.77
Market Cap: $5.24B
P/E (TTM): 78.96
EPS (TTM): 0.26
Dividend Yield: 5.84%

Advanced Metrics

Price/Book: 1.91
PEG Ratio: 5.28
Return on Equity: 2.39%
Return on Assets: 1.90%
Gross Margin: 50.27%
Operating Margin: -12.53%
Profit Margin: 7.58%
Current Ratio: 3.57
Debt/Equity: 0.96
Total Debt: $2.63B
Free Cash Flow: $155.12M
Revenue Growth: 25.30%
Earnings Growth: —
Enterprise Value: $7.63B

SBRA Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$624.81M	$647.51M	$703.24M	$774.63M
Cost of Revenue	$162.61M	$195.25M	$227.09M	$271.11M
Gross Profit	$462.20M	$452.27M	$476.15M	$503.53M
Selling, General & Admin	$39.57M	$47.47M	$50.07M	$53.71M
Operating Expenses	$227.36M	$230.56M	$219.69M	$239.66M
Operating Income	$234.84M	$221.71M	$256.46M	$263.87M
EBITDA	$216.89M	$311.81M	$412.61M	$456.83M
Pretax Income	-$76.36M	$15.76M	$127.72M	$157.35M
Income Tax	$1.24M	$2.00M	$1.00M	$1.84M
Net Income	-$77.61M	$13.76M	$126.71M	$155.61M
Diluted EPS	-0.34	0.06	0.54	0.64
Diluted Shares	230.95M	232.79M	236.05M	244.50M

SBRA Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$49.31M	$41.28M	$60.47M	$71.54M
Receivables	$147.91M	$133.81M	$131.75M	$111.29M
Current Assets	$201.84M	$180.53M	$198.09M	$189.43M
Total Assets	$5.75B	$5.39B	$5.30B	$5.49B
Current Liabilities	$339.24M	$231.41M	$224.45M	$336.91M
Long-Term Debt	$2.31B	$2.32B	$2.31B	$2.31B
Total Debt	$2.55B	$2.45B	$2.44B	$2.55B
Total Liabilities	$2.69B	$2.58B	$2.56B	$2.67B
Retained Earnings	-$1.45B	-$1.72B	-$1.87B	-$2.01B
Shareholders' Equity	$3.06B	$2.80B	$2.74B	$2.82B
Working Capital	-$137.40M	-$50.88M	-$26.36M	-$147.48M
Net Debt	$2.46B	$2.37B	$2.36B	$2.46B

SBRA Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$315.73M	$300.57M	$310.54M	$348.61M
Free Cash Flow	$315.73M	$300.57M	$310.54M	$348.61M
Depreciation & Amortisation	$187.78M	$183.09M	$169.62M	$187.00M
Stock-Based Compensation	$7.45M	$7.92M	$8.99M	$11.36M
Investing Cash Flow	-$216.25M	$103.13M	-$109.00M	-$377.96M
Financing Cash Flow	-$161.71M	-$410.30M	-$181.56M	$40.76M
Dividends Paid	-$277.16M	-$277.45M	-$280.15M	-$289.50M
Share Repurchases	-$4.81M	-$2.68M	—	—
Net Change in Cash	-$62.22M	-$6.60M	$19.98M	$11.41M

SBRA Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$183.54M	$189.15M	$190.04M	$211.90M	$221.75M
Cost of Revenue	$59.93M	$61.10M	$69.65M	$80.42M	$85.64M
Gross Profit	$123.61M	$128.05M	$120.38M	$131.49M	$136.11M
Selling, General & Admin	$12.73M	$12.51M	$12.56M	$15.91M	$14.86M
Operating Expenses	$56.22M	$56.10M	$60.83M	$66.91M	$67.78M
Operating Income	$67.39M	$71.95M	$59.55M	$64.58M	$68.33M
EBITDA	$111.31M	$137.17M	$100.36M	$107.98M	$122.88M
Pretax Income	$40.72M	$66.04M	$22.95M	$27.64M	$41.34M
Income Tax	$413.00K	$497.00K	$436.00K	$491.00K	$526.00K
Net Income	$40.30M	$65.54M	$22.54M	$27.23M	$40.88M
Diluted EPS	0.17	0.27	0.09	0.11	0.16
Diluted Shares	240.30M	240.93M	243.56M	252.77M	255.97M

SBRA Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$22.65M	$95.17M	$200.60M	$71.54M	$116.53M
Receivables	$126.38M	$155.03M	$113.22M	$111.29M	$148.09M
Current Assets	$155.28M	$256.68M	$320.74M	$189.43M	$271.54M
Total Assets	$5.23B	$5.33B	$5.56B	$5.49B	$5.59B
Current Liabilities	$112.07M	$113.06M	$124.04M	$336.91M	$472.93M
Long-Term Debt	$2.39B	$2.48B	$2.59B	$2.31B	$2.31B
Total Debt	$2.42B	$2.50B	$2.61B	$2.55B	$2.69B
Total Liabilities	$2.53B	$2.62B	$2.74B	$2.67B	$2.80B
Retained Earnings	-$1.91B	-$1.91B	-$1.96B	-$2.01B	-$2.05B
Shareholders' Equity	$2.70B	$2.71B	$2.82B	$2.82B	$2.79B
Working Capital	$43.21M	$143.62M	$196.70M	-$147.48M	-$201.39M
Net Debt	$2.37B	$2.38B	$2.39B	$2.46B	$2.55B

SBRA Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$80.26M	$80.96M	$99.96M	$87.43M	$98.36M
Free Cash Flow	$80.26M	$80.96M	$99.96M	$87.43M	$98.36M
Depreciation & Amortisation	$43.49M	$43.59M	$48.51M	$51.41M	$53.13M
Stock-Based Compensation	$2.71M	$2.70M	$2.88M	$3.07M	$3.10M
Investing Cash Flow	-$16.44M	-$45.13M	-$199.84M	-$116.55M	-$105.09M
Financing Cash Flow	-$101.24M	$36.73M	$206.17M	-$100.89M	$52.10M
Dividends Paid	-$71.37M	-$71.38M	-$71.94M	-$74.81M	-$75.66M
Share Repurchases	-$5.39M	—	—	—	-$8.25M
Net Change in Cash	-$37.42M	$72.55M	$106.30M	-$130.01M	$45.37M

Market Snapshot

About

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in healthcare-related properties. The company focuses on skilled nursing facilities, senior housing, and specialty hospitals across the United States. Sabra generates revenue through triple-net leases and operating leases with healthcare operators.